Famulla S, Hvelmann U, Fischer A et al (2016) Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action and impaired postprandial glucose control
No funds from M3 were used in the writing of this manuscript
Oral GLP-1 small molecules are not guaranteed winners, because they must still clear exposure, liver safety, and gastrointestinal-tolerability hurdles
Superiority of Semaglutide over Dulaglutide Semaglutide showed a modest but significant advantage over dulaglutide for controlling diabetes and enhancing weight loss, Drucker says
Unlike Wegovy, which is approved for weight loss, Ozempic is not
Early signs of response include reduced appetite, smaller portion satisfaction, and declining fasting blood glucose or HbA1c in those with diabetes